Experimental Models of Brugada syndrome

Franziska Sendfeld, Elisabet Selga, Fabiana S Scornik, Guillermo J Pérez, Nicholas L Mills, Ramon Brugada

Research output: Contribution to journalReview articlepeer-review

Abstract / Description of output

Brugada syndrome is an inherited, rare cardiac arrhythmogenic disease, associated with sudden cardiac death. It accounts for up to 20% of sudden deaths in patients without structural cardiac abnormalities. The majority of mutations involve the cardiac sodium channel gene SCN5A and give rise to classical abnormal electrocardiogram with ST segment elevation in the right precordial leads V1 to V3 and a predisposition to ventricular fibrillation. The pathophysiological mechanisms of Brugada syndrome have been investigated using model systems including transgenic mice, canine heart preparations, and expression systems to study different SCN5A mutations. These models have a number of limitations. The recent development of pluripotent stem cell technology creates an opportunity to study cardiomyocytes derived from patients and healthy individuals. To date, only a few studies have been done using Brugada syndrome patient-specific iPS-CM, which have provided novel insights into the mechanisms and pathophysiology of Brugada syndrome. This review provides an evaluation of the strengths and limitations of each of these model systems and summarizes the key mechanisms that have been identified to date.

Original languageEnglish
JournalInternational Journal of Molecular Sciences
Issue number9
Publication statusPublished - 29 Apr 2019


Dive into the research topics of 'Experimental Models of Brugada syndrome'. Together they form a unique fingerprint.

Cite this